Skip to main content
. 2023 Aug 31;46(2):1543–1560. doi: 10.1007/s11357-023-00917-z

Fig. 4.

Fig. 4

A Changes in protein abundances across multiple longevity treatments in liver. Proteins shown are limited to those with an absolute log2 fold-change ≥ 0.5 and a Bayes factor ≥ 10 in GHRKO, Snell dwarf, and at least one other drug or diet treatment contrasts of either sex. The color of the points indicates the associated Bayes factor and the size is proportional to the magnitude of the fold-change with closed points indicating a positive change and open points indicating a negative change. B GO-Terms that are enriched (with an associated adjusted p-value ≤ 0.01) among proteins with shared responses across longevity-promoting interventions in liver (shown in A)